Future Science Group期刊
Future Science Group期刊
期刊
会议
图书
×
筛选
期刊分组
出版时间
学科领域
导出到 
排序方式 :
最新发表 
共39,979条
Let us know your thoughts on reproducibility
作者：Francesca Lake
来源：[J].BioTechniques(IF 2.399), 2019, pp.-Future Science Group
全文获取
纸质馆藏
    Cancer immunotherapy-associated hypophysitis
    作者：Franklin Castillero , Omar Castillo-Fernández , Geiner Jiménez-Jiménez ...
    来源：[J].Future Oncol.(IF 3.202), 2019, pp.-Future Science Group
    摘要：The advances in cancer therapy have included the development of drugs that inhibit immune checkpoint ligands. Two types of immune checkpoint inhibitors, both antibodies that target CTLA-4 and PD-1, have been approved for its use in NSCLC and melanoma as first-line or second-line ...
    全文获取
    纸质馆藏
      Lung cancer and immunotherapy: a real-life experience from second line and beyond
      作者：Fady El Karak , Fady Gh Haddad , Roland Eid ...
      来源：[J].Future Oncol.(IF 3.202), 2019, pp.-Future Science Group
      摘要：Aim: This study assessed the efficacy of anti-PD-1/PD-L1 agents in real life when used in second line or beyond. Materials & methods: Patients with advanced non-small-cell lung cancer progressing after standard chemotherapy and receiving immunotherapy in the second line or b...
      全文获取
      纸质馆藏
        Industry update: the latest developments in the field of therapeutic delivery, April 2019
        作者：Peter Timmins
        来源：[J].Ther. Deliv., 2019, pp.-Future Science Group
        摘要：April 2019 was perhaps remarkable for the amount of industry news about gene therapy, and notably the announcement by a global contract development and manufacturing organization, Catalent, that it was creating a capability in gene therapy product development and manufacturi...
        全文获取
        纸质馆藏
          The current landscape of 3D printing in oncological surgical interventions
          作者：Georgia Makin
          来源：[J].Future Oncol.(IF 3.202), 2019, pp.-Future Science Group
          全文获取
          纸质馆藏
            The time of sentinel lymph node biopsy and neoadjuvant chemotherapy in clinical negative axilla breast cancer: before or after?
            作者：Zhao Bi , Jingjing Liu , Peng Chen ...
            来源：[J].Future Oncol.(IF 3.202), 2019, Vol.15 (23), pp.2669-2671Future Science Group
            全文获取
            纸质馆藏
              Emerging strategies in the initial management of locally advanced rectal cancer
              作者：Lucy Gately , Hui-Li Wong , Jeanne Tie ...
              来源：[J].Future Oncol.(IF 3.202), 2019, pp.-Future Science Group
              摘要：The initial management of locally advanced rectal cancer continues to evolve and formulating the ideal treatment plan remains challenging, with a multitude of emerging treatment strategies and either limited or inconsistent data to support these. The main objective of neoadjuvant...
              全文获取
              纸质馆藏
                What could the future hold for treatment sequencing in cancer medicine? An interview with Angela Märten
                作者：Angela Märten , Rachel Jenkins
                来源：[J].Future Oncol.(IF 3.202), 2019, pp.-Future Science Group
                摘要：Professor Angela Märten speaks to Rachel Jenkins, Commissioning Editor Angela Märten earned her PhD at Humboldt University of Berlin, Germany, in 2000, after working for several years as an oncology nurse. Upon completion of her PhD, she assumed responsibility for Phase I tr...
                全文获取
                纸质馆藏
                  Spondylodiscitis due to Cutibacterium acnes following lumbosacral intradiscal biologic therapy: a case report
                  作者：Nicholas R Beatty , Cole Lutz , Kwadwo Boachie-Adjei ...
                  来源：[J].Regen. Med.(IF 3.873), 2019, pp.-Future Science Group
                  摘要：A 40-year-old woman with a history of chronic low back pain underwent a fluoroscopically guided intradiscal platelet-rich plasma injection (PRP) at the L5–S1 level. She subsequently developed progressive low back pain, night sweats and decreased ability to ambulate. Laborato...
                  全文获取
                  纸质馆藏
                    Natural killer cells and cancer therapy, what we know and where we are going
                    作者：Faezeh Ghaemdoust , Mahsa Keshavarz-Fathi , Nima Rezaei
                    来源：[J].Immunotherapy(IF 2.393), 2019, pp.-Future Science Group
                    摘要：Natural killer (NK) cells are among the significant components of innate immune system and they have come to the first line of defense against tumor cells developing inside the body. CD56lo/CD16+ NK cells are highly cytotoxic and CD56hi NK cells can produce cytokines and perform ...
                    全文获取
                    纸质馆藏
                      12345678910下页

                      我们正在为您处理中，这可能需要一些时间，请稍等。

                      资源合作：cnki.scholar@cnki.net,　+86-10-82896619　　 意见反馈：scholar@cnki.net

                      ×